{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-018543","form_type":"8-K","ticker":"NUWE","cik":"0001506492","company_name":"Nuwellis, Inc.","filed_at":"2025-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.528022+00:00","generated_at":"2026-05-21T15:11:35.071755+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nuwellis Q1 2025 revenue $1.9M (+3% YoY); net loss narrows to $3.0M","bullets":["Revenue $1.9M (+3% YoY); consumables utilization +4%; pediatric revenue +38%.","Operating expenses down 31% to $4.1M; operating loss improved to $3.1M from $4.7M.","Net loss $3.0M ($0.69/sh) vs $3.8M ($24.11/sh) in Q1 2024.","CMS reassigned Aquadex to higher outpatient reimbursement (4x to $1,639/day) effective Jan 1, 2025.","Cash $2.6M, debt-free."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-018543","json":"https://secwatch.observer/filing/0001140361-25-018543.json","markdown":"https://secwatch.observer/filing/0001140361-25-018543.md","text":"https://secwatch.observer/filing/0001140361-25-018543.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506492/000114036125018543/0001140361-25-018543-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506492/000114036125018543/ef20048675_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T15:11:35.071755+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}